Keros Therapeutics (KROS) Amortizatization of Intangibles (2019 - 2025)

Keros Therapeutics (KROS) has reported Amortizatization of Intangibles for 7 consecutive years, with $622000.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Amortizatization of Intangibles rose 8.74% year-over-year to $622000.0; the trailing twelve-month figure through Dec 2025 stood at $2.4 million (up 32.42% YoY), and the FY2025 full-year result was $2.4 million, up 32.42% from the prior year.
• Amortizatization of Intangibles advanced to $622000.0 in Q4 2025 per KROS's latest filing, from $609000.0 in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $622000.0 in Q4 2025 and bottomed at $99000.0 in Q1 2021.
• Historically, Amortizatization of Intangibles has averaged $362150.0 across 5 years, with a median of $340000.0 in 2023.
• The sharpest annual moves came in 2023 and 2024: Amortizatization of Intangibles soared 157.14% in 2023, then sank 35.06% in 2024.
• Over 5 years, Amortizatization of Intangibles stood at $198000.0 in 2021, then jumped by 62.12% to $321000.0 in 2022, then increased by 4.36% to $335000.0 in 2023, then surged by 70.75% to $572000.0 in 2024, then rose by 8.74% to $622000.0 in 2025.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $622000.0, $609000.0, and $595000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.